Category:Tryptamines
Appearance
class of indoles | |||||
| Upload media | |||||
| Instance of |
| ||||
|---|---|---|---|---|---|
| Subclass of | |||||
| Different from | |||||
| |||||
Subcategories
This category has the following 47 subcategories, out of 47 total.
5
- 5-Chloro-AET (1 F)
- 5-Chloro-AMT (2 F)
- 5-Chloro-DMT (3 F)
- 5-Fluoro-AET (2 F)
- 5-Fluoro-AMT (4 F)
- 5-Fluoro-DET (2 F)
- 5-Fluoro-DMT (3 F)
- 5-Fluoro-EPT (2 F)
- 5-Fluoro-MET (3 F)
- 5-MeO-T-NBOMe (4 F)
- 5-TFMO-DMT (2 F)
6
- 6-Fluoro-AMT (3 F)
- 6-Fluoro-DET (2 F)
A
- AL-37350A (5 F)
B
- Baeocystin (8 F)
- Bufotenin (12 F)
- BW-723C86 (3 F)
C
- Convolutindole A (3 F)
- CP-132,484 (5 F)
D
- Dibutyltryptamine (3 F)
- Diethyltryptamine (7 F)
- 5,7-Dihydroxytryptamine (4 F)
- Diisopropyltryptamine (6 F)
- Dipropyltryptamine (9 F)
E
- Ethocybin (6 F)
- 5-Ethyl-DMT (3 F)
- Alpha-Ethyltryptamine (6 F)
- N-Ethyltryptamine (8 F)
H
- Hydroxytryptophan (14 F)
I
- Indorenate (3 F)
L
- Luvesilocin (2 F)
M
- Methylbutyltryptamine (3 F)
- Methylethyltryptamine (2 F)
- Alpha-Methyltryptamine (10 F)
- N-Methyltryptamine (6 F)
N
- NDTDI (4 F)
- Norbaeocystin (7 F)
O
- O-4310 (4 F)
P
S
- Sumatriptan (18 F)
T
Media in category "Tryptamines"
The following 200 files are in this category, out of 519 total.
(previous page) (next page)-
(BrMT)2.png 1,824 × 821; 73 KB
-
(R)-5-Fluoro-MPMI.svg 101 × 83; 6 KB
-
(R)-5-MeO-MPMI.svg 111 × 83; 6 KB
-
(R)-Lucigenol ((R)-4-HO-MPMI).svg 86 × 83; 6 KB
-
1-iPr-6-F-4-HO-DMT 3D.png 1,156 × 969; 256 KB
-
1-Methyl-DMT.svg 81 × 83; 4 KB
-
1-Methylpsilocin 3D.png 1,169 × 890; 223 KB
-
1-Methylpsilocin structure.png 326 × 336; 11 KB
-
1-Methylpsilocin.svg 82 × 83; 5 KB
-
1-Methyltryptamine.svg 81 × 77; 4 KB
-
1-Propyl-5-MeO-AMT structure.svg 106 × 94; 5 KB
-
1-TMT 3D.png 1,203 × 903; 224 KB
-
2,3-Dihydro-DMT structure.svg 410 × 410; 4 KB
-
2,N,N-TMT 3D.png 1,256 × 939; 230 KB
-
2-Azapsilocin structure.png 675 × 692; 18 KB
-
2-Et-5-MeO-DMT.png 384 × 330; 12 KB
-
2-HO-NMT 3D.png 1,226 × 1,066; 246 KB
-
2-Hydroxy-NMT.svg 81 × 76; 5 KB
-
2-Iodomelatonin.png 1,083 × 788; 48 KB
-
2-Me-5-Cl-DMT 3D.png 1,248 × 1,200; 273 KB
-
2-Me-DET 3D.png 1,180 × 972; 256 KB
-
2-Methyl-DiPT chemical structure.svg 91 × 96; 5 KB
-
2-Methyl-iPALT 3D.png 1,172 × 937; 249 KB
-
2-Methyl-iPALT.svg 100 × 96; 6 KB
-
2-methylserotonin 3D.png 1,081 × 839; 221 KB
-
2-MT 3D.png 1,207 × 900; 217 KB
-
3-APB 3D.png 1,158 × 733; 210 KB
-
3-Pentyl psilocinyl methylphosphonate chemical structure.png 375 × 364; 11 KB
-
310psilo.png 297 × 222; 12 KB
-
4,5-DHP-1-Me-T 3D.png 1,191 × 1,097; 241 KB
-
4,5-DHP-AMT 3D.png 1,261 × 926; 231 KB
-
4,5-DHP-DMT 3D.png 1,274 × 867; 239 KB
-
4,5-Dihydroxytryptamine.svg 106 × 76; 5 KB
-
4,5-MDO-DiPT 3D.png 1,144 × 817; 249 KB
-
4,5-MDO-DMT 3D.png 1,360 × 1,035; 270 KB
-
4-AcO-DALT 3D.png 1,315 × 1,044; 294 KB
-
4-AcO-DiPT 3D.png 1,197 × 853; 261 KB
-
4-AcO-DMT 3D.png 1,256 × 958; 246 KB
-
4-AcO-DMT structure.svg 93 × 84; 6 KB
-
4-AcO-EPT.svg 112 × 96; 6 KB
-
4-AcO-MALT 2D.svg 323 × 249; 9 KB
-
4-AcO-MALT 3D.png 1,285 × 885; 265 KB
-
4-AcO-MALT.svg 112 × 91; 6 KB
-
4-AcO-MET 3D.png 1,297 × 989; 264 KB
-
4-AcO-MPT structure.png 982 × 609; 30 KB
-
4-AcO-MPT.svg 112 × 91; 6 KB
-
4-Aza-5-MeO-DPT structure.png 911 × 857; 25 KB
-
4-F-5-MeO-DMT 3D.png 1,206 × 743; 211 KB
-
4-F-5-MeO-pyr-T 3D.png 1,253 × 692; 208 KB
-
4-Fluoro-DMT.svg 81 × 82; 5 KB
-
4-Fluorotryptamine structure.svg 410 × 380; 5 KB
-
4-GO-DiPT 3D.png 1,182 × 1,107; 268 KB
-
4-GO-DMT 3D.png 1,243 × 888; 235 KB
-
4-HO-5-MeO-DMT 3D.png 1,244 × 861; 240 KB
-
4-HO-AET 2D.svg 86 × 76; 5 KB
-
4-HO-AET 3D.png 1,126 × 826; 227 KB
-
4-HO-DALT 2D.svg 100 × 107; 6 KB
-
4-HO-DALT 3D.png 1,269 × 783; 235 KB
-
4-HO-DBT 3D.png 1,322 × 998; 257 KB
-
4-HO-DET 3D.png 1,128 × 772; 227 KB
-
4-HO-DiBT.svg 105 × 106; 6 KB
-
4-HO-DiPT 3D.png 1,228 × 692; 216 KB
-
4-HO-DsBT 3D.png 1,134 × 715; 229 KB
-
4-HO-DsBT structure.svg 100 × 106; 6 KB
-
4-HO-DtBT.svg 96 × 95; 6 KB
-
4-HO-EiBT 2D.svg 100 × 99; 6 KB
-
4-HO-EiBT 3D.png 1,197 × 802; 225 KB
-
4-HO-EiPT 3D.png 1,156 × 733; 222 KB
-
4-HO-EiPT.svg 227 × 253; 6 KB
-
4-HO-iPALT chemical structure.svg 91 × 107; 6 KB
-
4-HO-MALT 2D.svg 100 × 91; 5 KB
-
4-HO-MALT 3D.png 1,245 × 742; 210 KB
-
4-HO-MBT 3D.png 1,286 × 739; 213 KB
-
4-HO-MBT.svg 104 × 105; 5 KB
-
4-HO-McPT 3D.png 1,218 × 681; 207 KB
-
4-HO-MiPT 3D.png 1,206 × 770; 218 KB
-
4-HO-MPMI 2D.svg 264 × 213; 8 KB
-
4-HO-MPMI 3D.png 1,255 × 811; 256 KB
-
4-HO-MsBT.svg 100 × 91; 5 KB
-
4-HO-MtBT chemical structure.svg 95 × 88; 5 KB
-
4-HO-NALT 2D.svg 101 × 91; 5 KB
-
4-HO-NALT 3D.png 1,221 × 699; 189 KB
-
4-HO-NBnT 2D.svg 104 × 116; 7 KB
-
4-HO-NBnT 3D.png 1,324 × 681; 232 KB
-
4-HO-NBnT structure.png 945 × 630; 34 KB
-
4-HO-NBT chemical structure.svg 104 × 105; 5 KB
-
4-HO-NcHT chemical structure.svg 109 × 91; 6 KB
-
4-HO-NET.svg 86 × 88; 5 KB
-
4-HO-NiBT chemical structure.svg 100 × 99; 5 KB
-
4-HO-NiPT 3D.png 1,239 × 693; 225 KB
-
4-HO-NiPT.svg 91 × 88; 5 KB
-
4-HO-NMT 3D.png 1,246 × 867; 229 KB
-
4-HO-NPT.svg 100 × 91; 5 KB
-
4-HO-NsBT chemical structure.svg 100 × 91; 5 KB
-
4-HO-NtBT chemical structure.svg 95 × 88; 5 KB
-
4-HO-PiPT 3D.png 1,201 × 795; 226 KB
-
4-HO-pyr-T 3D.png 1,348 × 818; 246 KB
-
4-HO-TMT 3D.png 1,168 × 793; 219 KB
-
4-HO-αMT 3D.png 1,261 × 848; 233 KB
-
4-HT 3D.png 1,213 × 977; 232 KB
-
4-Hydroxy-5-methoxytryptamine.svg 107 × 75; 5 KB
-
4-Hydroxytryptamine.svg 82 × 76; 5 KB
-
4-MeO-DET 3D.png 1,159 × 810; 222 KB
-
4-MeO-DET.svg 86 × 96; 5 KB
-
4-MeO-DiPT.svg 90 × 95; 6 KB
-
4-MeO-DMT chemical structure.svg 81 × 82; 5 KB
-
4-Methoxytryptamine 3D.png 1,213 × 986; 237 KB
-
4-Methoxytryptamine structure.svg 81 × 76; 5 KB
-
4-Methoxytryptamine.svg 455 × 375; 10 KB
-
4-Methyl-AET.svg 86 × 76; 5 KB
-
4-Methyl-AMT.svg 82 × 75; 5 KB
-
4-Methyl-DMT.svg 81 × 81; 5 KB
-
4-PO-TMT 3D.png 1,171 × 940; 263 KB
-
4-PrO-DiPT 2D.svg 354 × 256; 9 KB
-
4-PrO-DiPT 3D.png 1,182 × 874; 266 KB
-
4-PrO-DiPT.svg 116 × 95; 7 KB
-
4-PrO-MET.svg 110 × 88; 6 KB
-
5,6-Br-DMT.png 1,138 × 741; 201 KB
-
5,6-Dibromo-NMT 3D.png 1,274 × 924; 212 KB
-
5,6-dibromotryptamine 3D.png 1,055 × 865; 176 KB
-
5,6-Dihydroxytryptamine.svg 495 × 363; 12 KB
-
5,6-FUR-DMT structure.png 808 × 672; 21 KB
-
5,6-MDO-DiPT 3D.png 1,195 × 797; 250 KB
-
5,6-MDO-DMT 3D.png 1,264 × 763; 214 KB
-
5,6-MDO-MiPT 3D.png 1,260 × 700; 212 KB
-
5,6-MeO-MiPT 3D.png 1,280 × 788; 209 KB
-
5,N,N-TMT 3D.png 1,232 × 858; 216 KB
-
5,N,N-TMT.svg 93 × 82; 5 KB
-
5-AcO-DMT 3D.png 1,216 × 759; 203 KB
-
5-Allyloxy-AMT 3D.png 1,190 × 694; 192 KB
-
5-Allyloxy-AMT.svg 131 × 76; 6 KB
-
5-Aza-4-MeO-DiPT structure.png 796 × 785; 24 KB
-
5-Benzyloxytryptamine chemical structure.svg 145 × 76; 7 KB
-
5-BnO-DMT structure.png 1,140 × 682; 26 KB
-
5-Bromo-DMT 3D.png 1,203 × 937; 213 KB
-
5-Bromo-MPMI.svg 106 × 83; 5 KB
-
5-Bromotryptamine.svg 515 × 380; 5 KB
-
5-BT 2D.svg 420 × 222; 10 KB
-
5-BT 3D.png 1,187 × 713; 182 KB
-
5-Carboxamidotryptamine.png 460 × 306; 12 KB
-
5-Carboxamidotryptamine.svg 193 × 122; 20 KB
-
5-Chloro-AET.svg 106 × 76; 5 KB
-
5-Chloro-αET 3D.png 1,209 × 913; 220 KB
-
5-Chlorotryptamine.svg 515 × 380; 5 KB
-
5-CN-DMT structure.png 864 × 688; 21 KB
-
5-CN-DPT structure.png 1,007 × 822; 26 KB
-
5-CT 3D.png 1,204 × 912; 231 KB
-
5-Ethoxy-DMT 3D.png 1,279 × 725; 208 KB
-
5-Ethoxy-αMT 3D.png 1,139 × 761; 194 KB
-
5-Ethyl-DMT 3D.png 1,228 × 941; 251 KB
-
5-F-DiPT structure.png 861 × 720; 22 KB
-
5-F-DPT structure.png 945 × 790; 23 KB
-
5-F-MET 3D.png 1,207 × 808; 212 KB
-
5-Fluoro-AET 3D.png 1,198 × 850; 216 KB
-
5-Fluoro-AMT 3D.png 1,166 × 840; 222 KB
-
5-Fluoro-DET 3D.png 1,132 × 775; 226 KB
-
5-Fluoro-DMT 3D.png 1,190 × 853; 205 KB
-
5-Fluoro-DMT.svg 96 × 82; 5 KB
-
5-Fluoro-MPMI 2D.svg 312 × 213; 7 KB
-
5-Fluoro-MPMI 3D.png 1,206 × 707; 220 KB
-
5-Fluoro-MPMI.svg 101 × 83; 5 KB
-
5-Fluorotryptamine structure.svg 97 × 76; 5 KB
-
5-Fluorotryptamine.svg 490 × 325; 10 KB
-
5-HO-DET 2D.svg 109 × 96; 5 KB
-
5-HO-DET 3D.png 1,196 × 825; 223 KB
-
5-HO-DiPT 3D.png 1,165 × 795; 244 KB
-
5-HO-DPT 3D.png 1,194 × 784; 222 KB
-
5-HO-MiPT.svg 114 × 88; 5 KB
-
5-Hydroxytryptophan alt.svg 121 × 76; 6 KB
-
5-I-DMT structure.png 1,128 × 898; 28 KB
-
5-Iodo-DMT.svg 95 × 82; 5 KB
-
5-iPr-DMT structure.png 846 × 680; 15 KB
-
5-iPrO-AMT structure.png 924 × 606; 21 KB
-
5-Me-MIPT.svg 346 × 286; 11 KB
-
5-Me-MiPT.svg 376 × 271; 10 KB
-
5-MeO-2-TMT 3D.png 1,250 × 917; 249 KB
-
5-MeO-4-TMT.svg 107 × 81; 5 KB
-
5-MeO-7-TMT 2D.svg 107 × 85; 5 KB
-
5-MeO-7-TMT 3D.png 1,201 × 883; 218 KB
-
5-MeO-AET 3D.png 1,260 × 1,024; 254 KB
-
5-MeO-AMT 3D.png 1,282 × 878; 222 KB
-
5-MeO-DiBT.svg 129 × 106; 6 KB
-
5-MeO-DMT vertical structure.svg 82 × 89; 5 KB
-
5-MeO-DsBT.svg 125 × 107; 6 KB
-
5-MeO-DtBT.svg 120 × 95; 6 KB
-
5-MeO-EiPT 3D.png 1,171 × 779; 233 KB
-
5-MeO-EiPT.svg 115 × 95; 6 KB
-
5-MeO-iPALT 2D.svg 125 × 95; 6 KB
-
5-MeO-iPALT 3D.png 1,238 × 910; 248 KB
-
5-MeO-IsoqT 3D.png 1,299 × 1,050; 288 KB
-
5-MeO-IsoqT.svg 117 × 108; 7 KB
-
5-MeO-MALT 3D.png 1,291 × 772; 224 KB
-
5-MeO-MALT.svg 124 × 92; 6 KB
-
5-MeO-MBT.svg 645 × 520; 6 KB
-
5-MeO-MET 3D.png 1,245 × 928; 234 KB
-
5-MeO-mor-T chemical structure.svg 110 × 103; 6 KB
-
5-MeO-MPMI 3D.png 1,047 × 857; 210 KB
-
5-MeO-MPT 2D.svg 125 × 91; 5 KB
-
5-MeO-MPT 3D.png 1,309 × 805; 217 KB
-
5-MeO-MsBT.svg 125 × 91; 6 KB